GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.02
Tradestie Score
63
Market Cap
$899.60M
Revenue Growth
0.3%
Analyst Upside
+243.1%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 51 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$163.94
|
$699.30M | - | 33 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$9.68
|
$665.30M | 11.1 | 52 | Compare |
|
ANL
ANL
|
$10.85
|
$641.40M | - | 39 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$16.80
|
$626.91M | - | 39 | Compare |
|
SVRA
Savara Inc.
|
$4.99
|
$611.84M | - | 55 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$9.09
|
$541.60M | - | 49 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$11.47
|
$540.97M | - | 33 | Compare |
More GERN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry